Investing Profile

Tim Shannon

VCInvestor
General Partner at Canaan Partners
canaan.com/team/tim-shannonWestport, Connecticut
Photo of Tim Shannon, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Canaan Partners General Partner
$250K - $20.0M
$10.0M
28
$800M
CompanyStageDateRound SizeTotal Raised
Vivace Therapeutics
Series DMar 2025$35M
Series CDec 2020$30M
Series BJun 2017$25M
Series AJan 2015$15M
$110M
Co-investors: Jake Simson (RA Capital)
Normunity
Series BJan 2025$75M
Series AOct 2022$65M
$140M
Co-investors: Paulina Hill (Polaris Partners), Sara Nayeem (Avoro Ventures)
Halda Therapeutics
Series BAug 2024$130M
Series BDec 2021$51M
Series AFeb 2019$25M
$200M
Co-investors: Arjun Goyal (Vida Ventures)
Acesion Pharma
Series BSep 2023$48M
$51M
Co-investors: Christopher de Souza (Broadview Ventures)
Aer Therapeutics
Series AApr 2023$36M
$36M
Co-investors: Rishi Gupta (OrbiMed), Christy Shaffer (Hatteras Venture Partners)
Rallybio
Series BApr 2020$150M
Series AApr 2018$37M
$180M
NextCure
Series BNov 2018$93M
Series AJan 2016$67M
$160M
Co-investors: Colleen Cuffaro (Canaan Partners)
Arvinas
Series CApr 2018$55M
Series BOct 2015$42M
Series ASep 2013$15M
$140M
Co-investors: Kush Parmar (5am Ventures), Colleen Cuffaro (Canaan Partners), Stephen Squinto (OrbiMed), Daniel Wagner (Connecticut Innovations), Andrew Levin (RA Capital), Jakob Loven (Nextech Invest), Martin Alexander Gershon (Endeavor Venture Funds)